Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women

The Lancet

Volumn 337, Issue 8741, 1991, Pages 612-

  Soma, Maurizio ^a   Fumagalli, Remo ^a   Paoletti, Rodolfo ^a   Meschia, Michele ^a   Maini, MichelaCarena ^a   Crosignani, Piergiorgio ^a   Ghanem, Karima ^b   Gaubatz, John ^b   Morrisett, JoelD ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; LIPOPROTEIN A;

ADULT; FEMALE; HEART DISEASE; HUMAN; HUMAN EXPERIMENT; LETTER; MENOPAUSE; PLASMA; PRIORITY JOURNAL; RISK ASSESSMENT;

COMPARATIVE STUDY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EVALUATION STUDIES; FEMALE; HUMAN; LIPOPROTEIN(A); LIPOPROTEINS; MEDROXYPROGESTERONE; MENOPAUSE; MIDDLE AGE;

EID: 0026035002     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(91)91674-J     Document Type: Letter

References (6)

1. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography
2. Lipoprotein LP(a) a risk factor for myocardial infarction
3. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B
4. Lipoprotein (a) m PROCAM participants and young myocardial infarction survivors
5. Quantitation, isolation, and characterisation of human lipoprotein(a)